AG003S4U

70476-82-3 | 9,​10-​Anthracenedione, 1,​4-​dihydroxy-​5,​8-​bis[[2-​[(2-​hydroxyethyl)​amino]​ethyl]​amino]​-​, hydrochloride (1:2)

Chemical structure of 9,​10-​Anthracenedione, 1,​4-​dihydroxy-​5,​8-​bis[[2-​[(2-​hydroxyethyl)​amino]​ethyl]​amino]​-​, hydrochloride (1:2), CAS 70476-82-3
AG003S4U
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 70476-82-3
Catalog Number AG003S4U(AGN-PC-0JKY3L)
Chemical Name 9,​10-​Anthracenedione, 1,​4-​dihydroxy-​5,​8-​bis[[2-​[(2-​hydroxyethyl)​amino]​ethyl]​amino]​-​, hydrochloride (1:2)
EC Number 274-619-1
IUPAC Name 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;dihydrochloride
InChI InChI=1S/C22H28N4O6.2ClH/c27-11-9-23-5-7-25-13-1-2-14(26-8-6-24-10-12-28)18-17(13)21(31)19-15(29)3-4-16(30)20(19)22(18)32;;/h1-4,23-30H,5-12H2;2*1H
InChI Key ZAHQPTJLOCWVPG-UHFFFAOYSA-N
MDL Number MFCD00242943
Molecular Formula C22H29ClN4O6
Molecular Weight 480.9419
SMILES Cl.N(CCNCCO)c1c2c(c(cc1)NCCNCCO)C(=O)c1c(C2=O)c(O)ccc1O
UNII U6USW86RD0
Synonyms
Acetate, Mitoxantrone, CL 232325, CL-232325, CL232325, DHAQ, Hydrochloride, Mitoxantrone, Mitoxantrone, Mitoxantrone Acetate, Mitoxantrone Hydrochloride, Mitozantrone, Mitroxone, Novantron, Novantrone, NSC 279836, NSC 287836, NSC 299195, NSC 301739, NSC 301739D, NSC-279836, NSC-287836, NSC-299195, NSC-301739, NSC-301739D, NSC279836, NSC287836, NSC299195, NSC301739, NSC301739D, Onkotrone, Pralifan, Ralenova, Mitoxantrone hydrochloride, 70476-82-3, Mitoxantrone dihydrochloride, Mitoxantrone HCl, Novantron, Novantrone, Immunex, Bisantrone, CL-232315, UNII-U6USW86RD0, DHAD, Mitoxantrone 2HCl, Mitoxantrone (dihydrochloride), CCRIS 2592, HSDB 6543, MITOXANTHRONE HYDROCHLORIDE, Mitozantrone hydrochloride, EINECS 274-619-1, NSC 301739, NSC-301739, U6USW86RD0, 1,4-dihydroxy-5,8-bis-[2-(2-hydroxyethylamino)ethylamino]anthraquinone 2hcl, CL 232315, CHEBI:50727, novatrone, MFCD00242943, 1,4-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)anthracene-9,10-dione dihydrochloride, CL 232,315, 1,4-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)anthraquinone dihydrochloride, DSSTox_CID_25173, DSSTox_RID_80722, DSSTox_GSID_45173, 1,4-Dihydroxy-5,8-bis-[2-(2-hydroxyethylamino)ethylamino]anthraquinone dihydrochloride, 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthraquinone dihydrochloride, 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-dihydroanthracene-9,10-dione dihydrochloride, 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione dihydrochloride, 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-, dihydrochloride, NCGC00015693-02, CAS-70476-82-3, Onkotrone, Ralenova, Eslep, SR-01000076001, mitoxanthrone hcl, Mitoxantrone Dihcl, Novantron (TN), 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione dihydrochloride, 1,4-dihydroxy-5,8-bis(2-(2-hydroxyethylamino)ethylamino)anthracene-9,10-dione dihydrochloride, 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione dihydrochloride, Prestwick_571, ACMC-20enxy, Mitoxantrone hydrochloride [USAN:JAN], Mitoxantrone hydrochloride [USAN:USP:JAN], AC1L1AED, Mitoxantrone-Hydrochloride, Mitroxantrone Hydrochloride, mitozantrone dihydrochloride, SCHEMBL3928, NSC-310739;Novantrone, SPECTRUM1503278, C22H28N4O6.2HCl, C22H30Cl2N4O6, AC1Q3B38, CHEMBL1417019, DTXSID0045173, CTK8F1285, KS-00000XLU, ZAHQPTJLOCWVPG-UHFFFAOYSA-N, HMS1569M11, HMS1922O21, BCP23424, dhaq dihydrochloride 65271-80-9, Tox21_110197, Tox21_500779, CCG-39938, HY-13502A, s2485, Mitoxantrone hydrochloride (JAN/USP), AKOS015895228, Tox21_110197_1, AC-1591, BCP9000932, CS-2525, LP00779, NSC-310739, NCGC00015693-09, NCGC00094116-01, NCGC00094116-02, NCGC00094116-03, NCGC00094116-04, NCGC00261464-01, AK163016, AS-13162, BC215535, H492, LS-20325, BCP0726000265, AB0013075, AB2000351, TL8004973, TX-017757, EU-0100779, ST24048109, SW196745-5, Mitoxantrone dihydrochloride, >=97% (HPLC), D02166, M 6545, X-2300, 271M809, I06-0260, SR-01000076001-1, SR-01000076001-8, W-104553, Z2569867923, Mitoxantrone dihydrochloride pound>>Mitozantrone dihydrochloride, 70476-82-3,65271-80-9(freebase),70711-41-0(diacetate), Mitoxantrone hydrochloride, European Pharmacopoeia (EP) Reference Standard, 1,4-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino-ethyl)amino)anthraquinone dihyrochloride, 1,4-dihydroxy-5,8-bis-[[2-(2-hydroxyethylamino)ethyl]amino]-anthraquinone dihydrochloride, 1,4-Dihydroxy-5,8-bis-[2-(2-hydroxy-ethylamino)-ethylamino]-anthraquinone dihydrochloride, 1,4-dihydroxy-5,8-bis-[2-(2-hydroxyethylamino)ethylamino]anthraquinonedihydrochloride, 1,4-dihydroxy-5,8-bis[[2-(2-hydroxyethylamino)ethyl]amino]anthraquinone dihydrochloride, Mitoxantrone hydrochloride, United States Pharmacopeia (USP) Reference Standard, 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;dihydrochloride, 9,10-Anthracenedione,1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-, dihydrochloride, mitoxantrone, Mitozantrone, Mitoxantron HCl, DHAQ, C22H28N4O6.2ClH, CID51082, DRG-0102, C22-H28-N4-O6.2Cl-H, ACN-039929, Mitoxantrone hydrochloride, 99% - 1G 1g, B2114, A10596, 65271-80-9, 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-, dihydrochloride, 1,4-Dihydroxy-5,8-bis([2-([2-hydroxyethyl]amino)ethyl]amino)-9,10-anthracenedione, 9,10-antracenediona, 1,4-dihidroxi-5,8-bis [[2-[(2-hidroxietil) amino] etil] amino]-, clorhidrato (1:2), DAD,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited